Atria Investments Inc Buys 977 Shares of Axon Enterprise, Inc $AXON

Atria Investments Inc grew its stake in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 24.5% in the second quarter, according to its most recent filing with the SEC. The institutional investor owned 4,966 shares of the biotechnology company’s stock after purchasing an additional 977 shares during the period. Atria Investments Inc’s holdings in Axon Enterprise were worth $4,112,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. TCI Wealth Advisors Inc. bought a new stake in Axon Enterprise during the 2nd quarter worth approximately $214,000. Duncker Streett & Co. Inc. boosted its stake in shares of Axon Enterprise by 3.2% in the 2nd quarter. Duncker Streett & Co. Inc. now owns 14,501 shares of the biotechnology company’s stock worth $12,006,000 after buying an additional 448 shares during the last quarter. Quotient Wealth Partners LLC purchased a new position in shares of Axon Enterprise in the 1st quarter worth approximately $438,000. New York Life Investment Management LLC boosted its stake in shares of Axon Enterprise by 3.2% in the 2nd quarter. New York Life Investment Management LLC now owns 11,044 shares of the biotechnology company’s stock worth $9,144,000 after buying an additional 341 shares during the last quarter. Finally, DAVENPORT & Co LLC boosted its stake in shares of Axon Enterprise by 5.1% in the 1st quarter. DAVENPORT & Co LLC now owns 940 shares of the biotechnology company’s stock worth $494,000 after buying an additional 46 shares during the last quarter. 79.08% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on AXON shares. Piper Sandler started coverage on Axon Enterprise in a research note on Tuesday, September 23rd. They issued an “overweight” rating and a $893.00 target price on the stock. Weiss Ratings restated a “hold (c)” rating on shares of Axon Enterprise in a research note on Wednesday, October 8th. JMP Securities restated a “market outperform” rating and issued a $825.00 target price on shares of Axon Enterprise in a research note on Monday, September 29th. Needham & Company LLC restated a “buy” rating and issued a $870.00 target price on shares of Axon Enterprise in a research note on Wednesday, September 24th. Finally, Craig Hallum upgraded Axon Enterprise from a “hold” rating to a “buy” rating and set a $900.00 target price on the stock in a research note on Tuesday, August 5th. Fourteen equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $841.64.

Insiders Place Their Bets

In other Axon Enterprise news, CFO Brittany Bagley sold 5,000 shares of the stock in a transaction on Monday, September 29th. The stock was sold at an average price of $713.88, for a total transaction of $3,569,400.00. Following the sale, the chief financial officer owned 93,592 shares in the company, valued at $66,813,456.96. This represents a 5.07% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, President Joshua Isner sold 15,919 shares of the stock in a transaction on Friday, August 15th. The stock was sold at an average price of $746.26, for a total value of $11,879,712.94. Following the sale, the president owned 238,379 shares in the company, valued at approximately $177,892,712.54. This represents a 6.26% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 59,932 shares of company stock valued at $45,115,616 in the last quarter. 4.40% of the stock is currently owned by company insiders.

Axon Enterprise Price Performance

Axon Enterprise stock opened at $732.23 on Friday. Axon Enterprise, Inc has a 12 month low of $422.38 and a 12 month high of $885.91. The company has a current ratio of 2.95, a quick ratio of 2.71 and a debt-to-equity ratio of 0.63. The business’s 50 day simple moving average is $731.05 and its 200 day simple moving average is $732.75. The company has a market cap of $57.48 billion, a price-to-earnings ratio of 180.80, a PEG ratio of 29.49 and a beta of 1.41.

Axon Enterprise (NASDAQ:AXON) last posted its quarterly earnings data on Monday, August 4th. The biotechnology company reported $2.12 EPS for the quarter, beating the consensus estimate of $1.54 by $0.58. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.The business had revenue of $668.54 million for the quarter, compared to the consensus estimate of $641.77 million. During the same quarter in the prior year, the business earned $1.20 earnings per share. Axon Enterprise’s revenue for the quarter was up 32.6% on a year-over-year basis. Axon Enterprise has set its FY 2025 guidance at EPS. Sell-side analysts forecast that Axon Enterprise, Inc will post 5.8 EPS for the current year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.